597th MEETING, LONDON 79 Meister, 1979~). In kidney and probably at other sites of high pglutamyl transpeptidase concentration, intracellular glutathione is transported to the membrane-bound enzyme; the products of enzyme action (y-glutamyl amino acids, cysteinylglycine) are taken up by the cell. Tissues such as muscle and liver, which have low activities of transpeptidase, transport glutathione to the blood plasma. Glutathione is removed from plasma by the action of transpeptidase, much of which is found in the kidney. A large fraction of the glutathione utilized by the kidney is transported out of renal cells. Studies on anephric animals indicate that about 70% of plasma glutathione is used by the kidney and the remainder by extrarenal transpeptidase (Griffith & Meister, 1 9 7 9~; Haberle et al., 1979) . Hepatic-vein plasma has a much higher concentration of glutathione than arterial plasma, and renal-venous plasma has about 20% of the glutathione content of arterial plasma (Anderson et al., 1980; Haberle et al., 1979) . These and other studies show that there is inter-organ transport of glutathione as well as an intra-organ cycle. Translocation of glutathione may function to provide a source of thiol to the cell membrane and its immediate environment. The interaction of glutathione with the transpeptidase thus seems to function in transport processes as well as in the recovery of the amino acid constituents of glutathione.
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Blocks at different steps of the y-glutamyl cycle have been found in certain patients and have also been achieved in animals by use of inhibitors. Studies on patients with glutathione synthetase deficiency led to the finding that glutathione normally feedback-inhibits pglutamylcysteine synthetase (Wellner et al., 1974; Richman & Meister, 1975; . Thus, with marked glutathione deficiency, y-glutamylcysteine is overproduced and converted by y-glutamyl cyclotransferase to 5-oxoproline. The accumulation of 5-oxoproline exceeds the capacity of 5-oxoprolinase so that 5-oxoproline concentrations increase in the blood and tissues and large quantities are excreted in the urine. Inhibition in vivo of 5-oxoprolinase produced by giving a competitive inhibitor leads to 5-oxoproline accumulation. Administration of an effective inhibitor of y-glutamyl cyclotransferase decreases tissue 5-oxoproline. Studies with model substrates of cyclotransferase (Bridges et al., 1980) and transpeptidase (Griffith & Meister, 1979b) provide measures of the extent of such inhibition in vivo. Inhibition of 5-oxoprolinase in viuo by administration of 2-oxothiazolidine-4-carboxylate inhibits utilization of 5-oxoproline, and leads also to an increase of liver glutathione because 2-oxothiazolidine-4-carboxylate is a substrate of 5-oxoprolinase, which converts this compound to cysteine (Williamson & Meister, 1981) . These findings (and studies that show that administration of L-2-oxothiazolidine-4-carboxylate to mice reverses the marked decreases in hepatic glutathione and associated toxicity produced by paracetamol) indicate that this compound can serve usefully as an intracellular delivery system for cysteine. Addition of an organic hydroperoxide or of hydrogen peroxide is accompanied by a decrease in intracellular GSH* and NADPH concentrations and a release of GSSG from the perfused rat liver (Sies et al., 1972) . The rate of GSSG release is dependent on the amount of hydroperoxide utilized and reflects intracellular GSH peroxidase activity (Sies & Summer, 1975) . H,O, generated intracellularly also gives rise to an increased GSSG release (Oshino & Chance, 1977) and this was found to occur specifically into bile (Sies et al., 19786) . The role of GSH in hepatic hydroperoxide metabolism was emphasized in studies Abbreviations: GSH, reduced glutathione; GSSG, oxidized glutathione.
VOl. 10 on liver deprived of intracellular GSH (Jones et al., 1978; Sies & Graf, 1981) or Se-GSH peroxidase (Burk et al., 1978; . In both systems GSSG efflux was not increased under conditions of peroxidative stress and in the GSH-depleted liver the intracellular concentration of H,O, was increased, detectable as an increased level of catalase Compound I. Conversely, inhibition of catalase by pretreating the rats with aminotriazole leads to elevated GSSG release probably dependent on intracellular GSSG concentrations (Oshino & Chance, 1977) .
Recently, the characteristics of GSSG efflux from the hepatocytes into bile was further investigated, and the relationship between intracellular GSSG and the rate of biliary GSSG transport was established in perfused rat liver (Fig. 1 ) (Akerboom et al., 1982) . Intracellular H,O, production was stimulated by the addition of substrates for monoamine oxidase, e.g. tryptamine, benzylamine or phenylethylamine, and was shown to cause an increase BIOCHEMICAL SOCIETY TRANSACTIONS in intracellular GSSG in isolated hepatocytes as well . These increases are associated with the functioning of the monoamine oxidase since they are sensitive to pargyline, an inhibitor of monoamine oxidase activity. Inhibition of GSH reductase by nitrofurantoin also leads to a pronounced GSSG efflux and increased levels of GSSG (Fig. 1) .
It is concluded that the rate of GSSG efRux across the canalicular membrane is dependent on the concentration of GSSG on the cytosolic side of the membrane. The calculated concentration gradient (assuming homogeneous distribution of GSSG in 0.55ml of intracellular water/g of liver) across the canalicular membrane is 5 1 + 4 (n = 19) in favour of the biliary space. The high concentration gradient across the canalicular membrane and the dependence of GSSG release on intracellular GSSG are consistent with the existence of a GSSG translocator. Such a translocase has been characterized in erythrocytes (Kondo et al., 1980) .
Formations of lipid hydroperoxides during the process of lipid peroxidation is accompanied by the generation of excited species that on decay to the ground state will emit light. Ultra-weak chemiluminescence, reflecting the formation of singlet oxygen, has been detected in isolated hepatocytes (Cadenas et al., 198 1) . Emission was increased in GSH-depleted cells and, further, was substantially decreased in such cells on addition of a thiol, dithioerythritol. These observations demonstrate the role of GSH in hepatic lipid hydroperoxide metabolism.
The glutathione S-transferases (EC 2.5.1.18) are multifunctional proteins that play an important part in the detoxification of xenobiotic compounds. In their catalytic role, they catalyse conjugation reactions between glutathione and a very wide range of second substrates. Typically, these second substrates are hydrophobic electrophiles and their conjugation with glutathione, which both increases their solubility in water and decreases their chemical reactivity, is the first step in a pathway that frequently leads to the urinary excretion of foreign compounds as acetylcysteine derivatives (i.e. mercapturic acids). The glutathione S-transferases have a second function since they can bind non-covalently to a variety of other ligands that are not substrates for conjugation. Because of the high concentrations of transferase proteins that are present in, for example, hepatic cytosol, and because of their high affinity for ligands as varied as lithocholic acid, cortisol and bilirubin. the glutathione Stransferases have an important transport function (for a recent review of this aspect see Smith & Litwack, 1980) . The third function of the glutathione S-transferase proteins in detoxification is related to their ability to act as trapping agents for strong electrophiles such as azo dye metabolites (Ketterer & Beale, 197 1) and polycyclic hydrocarbon derivatives (Singer & Litwack, 1971; Sarrif et al., 1978) . Here again the abundance of the protein is relevant and in rat liver they comprise 10% of the extractable protein (Jakoby et al.. 1976) . The enzymes are extremely widely distributed in Nature and activity has been detected in almost all the species, from bacteria (Meijer ef al.. 1980) to baboons (Chasseaud, 1979) , and tissues examined. This might be an indication that the original role of the enzymes was not concerned with the detoxification of foreign compounds.
The glutathione S-transferases and their roles in detoxification reactions have been expertly reviewed by Jakoby (1 978) and by Chasseaud (1979) ; what follows therefore draws attention to new information that has appeared that is relevant to the role of glutathione S-transferases in detoxification.
